| Supplier | Sagent Pharmaceuticals |
|---|---|
| Availability Status | ASHP Shortage + QS Availability Issues (2024-08-22) |
| Status Description |
QuicksortRx has identified an availability disruption across multiple channels, and ASHP has published an active drug shortage for this product. See their website for more information. |
| Quicksort Status | Availability Issues Detected (2024-08-22) |
| ASHP Status | ASHP Shortage Declared (2023-07-31) |
| QUMI Product Code | 2gxxbfj (QuicksortRx Universal Medication Identifier) |
| NDC | Package Count | Supplier | Description | Status | Updated |
|---|---|---|---|---|---|
| 24 | Hospira, Inc. | Ciprofloxacin 2 mg/mL Bag [Cipro] | No Availability Issues Detected | ||
| 24 | Sagent Pharmaceuticals | Ciprofloxacin 2 mg/mL Bag [Cipro] | No Availability Issues Detected | ||
| 1 | Baxter Healthcare Corporation | Ciprofloxacin 2 mg/mL Bag [Cipro] | No Availability Issues Detected | ||
| 1 | Baxter Healthcare Corporation | Ciprofloxacin 2 mg/mL Bag [Cipro] | No Availability Issues Detected |
| Previous Status | Status Start Date | Status End Date |
|---|---|---|
| ASHP Shortage + QS Availability Issues | 2024-08-22 | Current |
| No Availability Issues Detected | 2024-08-22 |
| RXCUI: | 1665211 |
|---|---|
| Dosage Form: | Bag |
| Dosage Route: | INJECTABLE |
| Strength: | 400 |
| Measure: | mg |
| ANDA: | ANDA078252 |
| Generic Description: | CIPROFLOXACIN |
| DEA: |